Form 4: Avidity Biosciences Executive Sells Shares to Cover Tax Obligations After RSU Vesting

Avidity Biosciences' Chief Scientific and Technology Officer, W. Michael Flanagan, sold 12,742 shares of common stock to cover tax obligations following the vesting of restricted stock units.

Summary

• W. Michael Flanagan, the Chief Scientific and Technology Officer of Avidity Biosciences, sold 12,742 shares of common stock on December 18, 2024.
• The sale was executed to cover tax withholding obligations related to the vesting of 25,000 time-based restricted stock units (RSUs).
• These RSUs were initially granted as performance-based restricted stock units (PSUs) and converted to time-based RSUs after a performance objective was met on June 17, 2024.
• The sale was mandated by the company's equity incentive plan, which requires a 'sell-to-cover' transaction to satisfy tax obligations.
• The shares were sold at a weighted-average price of $32.66, with individual transactions ranging from $32.66 to $32.66.
• Following the transaction, Flanagan beneficially owns 72,647 shares of Avidity Biosciences common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction related to executive compensation and tax obligations. It is neither particularly positive nor negative.

Risks

• The sale of shares by an executive, even for tax purposes, could be perceived negatively by some investors.

Management Comments

• The sale was mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a 'sell-to-cover' transaction and does not represent a discretionary trade by the Reporting Person.

Industry Context

This is a standard transaction for executives who receive equity compensation. It is common for companies to have 'sell-to-cover' policies to manage tax obligations related to vesting equity.

Comparison to Industry Standards

• Many biotechnology companies use restricted stock units (RSUs) as part of their compensation packages.
• It is common practice for executives to sell shares to cover tax obligations upon vesting of RSUs.
• The 'sell-to-cover' mechanism is a standard approach to manage tax liabilities associated with equity compensation.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment.

Key Dates

Keywords

Avidity Biosciences, insider trading, Form 4, stock sale, RSU, PSU, tax withholding, W. Michael Flanagan, equity incentive plan, sell-to-cover